Physician profile
John J Halperin
NPI 1124010079
$30,705.09
in general payments reported to CMS, 2019-2025
17 companies · $15K in 2025
The $15K reported for 2025 was more than what 91% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $69.64 · 2021: $2,511 · 2023: $6,284 · 2024: $6,519 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Food and Beverage: $35.16 · Education: $34.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,500.00 |
| Food and Beverage | $35.16 |
| Education | $34.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $30,000.00 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $116.80 | 2019-2020 | |
| Biogen, INC. | $110.43 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $91.66 | 2019-2024 | |
| Emd Serono, INC. | $79.89 | 2019 | |
| Alexion Pharmaceuticals, INC. | $49.78 | 2019-2023 | Ultomiris |
| Ge Healthcare | $43.06 | 2019 | |
| Boston Scientific Corporation | $36.50 | 2019 | |
| Akcea Therapeutics, INC. | $35.64 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $27.79 | 2019 | |
| Ucb, INC. | $26.33 | 2019 | |
| Amgen INC. | $16.26 | 2025 | Uplizna |
| Genentech USA, INC. | $14.88 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.66 | 2019 | |
| Csl Behring | $14.58 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.81 | 2019 | |
| Mdd US Operations, LLC | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Halperin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.